Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today

RZLT Insider Trading (Rezolute)

Insider Ownership Percentage: 4.60%
Insider Buying (Last 12 Months): $998,440.00
Insider Selling (Last 12 Months): $0.00

Rezolute Insider Trading History Chart

This chart shows the insider buying and selling history at Rezolute by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rezolute Share Price & Price History

Current Price: $12.99
Price Change: Price Decrease of -0.01 (-0.08%)
As of 06/24/2021 10:30 AM ET

This chart shows the closing price history over time for RZLT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today

Rezolute Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/24/2020Handok, Inc.Major ShareholderBuy250,000$0.45$112,500.00
9/22/2020Handok, Inc.Major ShareholderBuy250,000$0.46$115,000.00
9/18/2020Handok, Inc.Major ShareholderBuy125,000$0.46$57,500.00
9/9/2020Handok, Inc.Major ShareholderBuy250,000$0.47$117,500.00
9/1/2020Handok, Inc.Major ShareholderBuy250,000$0.52$130,000.00
8/27/2020Handok, Inc.Major ShareholderBuy250,000$0.47$117,500.00
8/25/2020Handok, Inc.Major ShareholderBuy250,000$0.50$125,000.00
8/4/2020Handok, Inc.Major ShareholderBuy125,000$0.34$42,500.00
7/31/2020Handok, Inc.Major ShareholderBuy375,000$0.32$120,000.00
7/16/2020Handok, Inc.Major ShareholderBuy250,000$0.19$47,500.00
7/14/2020Handok, Inc.Major ShareholderBuy84,000$0.16$13,440.00
See Full Table
Insider Trading at Rezolute?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Rezolute and related companies.

SEC Filings (Institutional Ownership Changes) for Rezolute (NASDAQ:RZLT)

29.67% of Rezolute stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RZLT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rezolute Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2021Millennium Management LLC26,924$0.19M0.0%N/A0.322%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC312,336$2.21M0.0%+2.7%3.740%Search for SEC Filing on Google Icon
5/17/2021Armistice Capital LLC288,000$2.03M0.0%-13.8%3.448%Search for SEC Filing on Google Icon
5/17/2021683 Capital Management LLC18,916$0.13M0.0%-52.7%0.226%Search for SEC Filing on Google Icon
2/16/2021Armistice Capital LLC333,990$4.01M0.1%N/A3.999%Search for SEC Filing on Google Icon
2/16/2021Caxton Corp424,243$5.09M3.2%N/A5.080%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.1,212,122$14.53M0.0%N/A14.513%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rezolute logo
Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also develops RZ402, a small molecule plasma kallikrein inhibitor, which is in preclinical stage for the treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Read More on Rezolute

Today's Range

Now: $12.99
Low: $12.99
High: $12.99

50 Day Range

MA: $8.80
Low: $6.11
High: $13.18

52 Week Range

Now: $12.99
Low: $3.50
High: $33.50

Volume

1 shs

Average Volume

38,246 shs

Market Capitalization

$108.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.71

Who are the company insiders with the largest holdings of Rezolute?

Rezolute's top insider shareholders include:
  1. Handok, Inc (Major Shareholder)

Who are the major institutional investors of Rezolute?

Rezolute's top institutional shareholders include:
  1. Citadel Advisors LLC — 3.74%
  2. Armistice Capital LLC — 3.45%
  3. Millennium Management LLC — 0.32%
  4. 683 Capital Management LLC — 0.23%

Which institutional investors are selling Rezolute stock?

During the last quarter, RZLT stock was sold by these institutional investors:
  1. Armistice Capital LLC
  2. 683 Capital Management LLC

Which institutional investors are buying Rezolute stock?

In the previous quarter, RZLT stock was bought by institutional investors including:
  1. Millennium Management LLC
  2. Citadel Advisors LLC
Why Are Billionaire Investors Betting On The 2021 Mental Health Revolution?
Investors say this little-known sector feels exactly like CBD did in 2017. This new technology is making investors like Peter Thiel very excited.
See How Early "Mental Health Revolution" Investors